![]()
![]() ![]() ![]()
|
||||
|
Published on
Wednesday, April 29, 2026
By the A.M. Costa Rica staff
A
U.S.-based clinical research company
is expanding its presence in Costa
Rica and creating new job
opportunities as it expands its
operations in San José. Intego
Clinical, headquartered in Maitland,
Florida, U.S., is the clinical
research division of Intego Group. The
company announced it is hiring as part
of an expansion at the San Pedro
Business Center
in San José. “The
growing specialization of Costa Rican
talent in data analytics and life
sciences continues to position the
country as a strategic base for
advanced clinical research, and that
is a key driver of the company’s
current and future growth,” said
Sergey Glushakov, CEO of Intego Group.
“Our
continued investment in Costa Rica
reflects a clear operational rationale:
strengthening Intego’s footprint across
the Americas and enabling full-time zone
coverage for our biometrics services,” he
added.
No prior
experience in the pharmaceutical
industry is required. Entry-level hires
will participate in a three-month paid
training program designed to prepare
them for roles as statistical
programmers. Interested candidates can
apply through the company’s careers
website. The firm
established operations in Costa Rica in
2024 and maintains a presence in the
United States, Poland, Ukraine, Armenia
and Romania. Costa Rica has
attracted steady foreign investment in
recent years, though employment
challenges persist. According to the
National Employment Survey (INEC), the
unemployment rate stood at 6.7% between
December 2025 and February 2026, leaving
more than 154,000 people without work.
Men accounted for about 56% of that
total, or roughly 87,000 individuals.
Intego Clinical is
among several U.S. companies expanding
in Costa Rica. Recently, Switchback
Medical, a medical device contract
development and manufacturing
organization based in Minnesota,
announced plans to build new
facilities in Alajuela province.
------------
|
||||